These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10437275)

  • 1. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of biocompatible dialysis membranes in acute renal failure.
    Himmelfarb J; Hakim RM
    Adv Ren Replace Ther; 1997 Apr; 4(2 Suppl 1):72-80. PubMed ID: 9113243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the dialysis membrane in the treatment of patients with acute renal failure.
    Hakim RM; Wingard RL; Parker RA
    N Engl J Med; 1994 Nov; 331(20):1338-42. PubMed ID: 7935703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemodialysis membranes: a historical perspective, current state and future prospect.
    Cheung AK; Leypoldt JK
    Semin Nephrol; 1997 May; 17(3):196-213. PubMed ID: 9165649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The influence of dialysis dose and the dialyzer membrane biocompatibility on the outcome of acute renal failure].
    Kes P; Sefer S
    Lijec Vjesn; 1999; 121(9-10):326-8. PubMed ID: 19662688
    [No Abstract]   [Full Text] [Related]  

  • 7. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatibility study based on differential sequestration kinetics of CD14+CD16+ blood monocyte subsets with different dialyzers.
    Griveas I; Visvardis G; Sakellariou G; Passadakis P; Thodis I; Vargemezis V; Pavlitou A; Fleva A
    Ren Fail; 2006; 28(6):493-9. PubMed ID: 16928619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioincompatibility--perspectives in 1993.
    Deppisch R; Ritz E; Hänsch GM; Schöls M; Rauterberg EW
    Kidney Int Suppl; 1994 Jan; 44():S77-84. PubMed ID: 8127038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
    Wauters JP
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report.
    Post JB
    Am J Kidney Dis; 2010 Jun; 55(6):e25-8. PubMed ID: 20110145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis membrane biocompatibility and mortality and morbidity in acute renal failure.
    Himmelfarb J; Hakim RM
    J Nephrol; 1997; 10(2):63-4. PubMed ID: 9238611
    [No Abstract]   [Full Text] [Related]  

  • 18. [A method of evaluating the degree of activation of the complement system in patients during hemodialysis].
    Tseitlina EA; Lanskaia IM; Marchenko AL; Rolikhin AE; Sevast'ianov VI
    Med Tekh; 1987; (5):39-43. PubMed ID: 3695894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research on dialyzers with improved biocompatibility.
    van der Steen A
    Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo model of hemodialysis membrane biocompatibility.
    Spencer PC; Schmidt B; Samtleben W; Bosch T; Gurland HJ
    Trans Am Soc Artif Intern Organs; 1985; 31():495-8. PubMed ID: 3879781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.